Evidence map›Paper›PMID 25438811›Full record

ArticleCNS oncology2014

Whole-brain radiotherapy in patients with brain metastases from melanoma.

Macarena de la Fuente, Kathryn Beal, Richard Carvajal, Thomas J Kaley

Abstract read
In one paragraph

Article in CNS oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Tumor Microenvironment in Melanoma Brain Metastasis: A New Potential Target?International journal of molecular sciences · 2025
    Review
  5. Review
  6. Systemic Therapy for Melanoma Brain and Leptomeningeal Metastases.Current treatment options in oncology · 2023
    Review
  7. Article
  8. Current Treatment of Melanoma Brain Metastasis.Current treatment options in oncology · 2020
    Review
  9. Review
  10. Article
  11. The Treatment of Melanoma Brain Metastases.Current oncology reports · 2016
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Macarena de la FuenteDepartment of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Kathryn Beal
Richard Carvajal
Thomas J Kaley

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo describe results of melanoma brain metastases (BM) treated with whole-brain radiation (WBRT).

methodsRetrospective review of patients with melanoma BM treated with WBRT divided into two groups based on the timing of WBRT (at BM diagnosis or recurrence).

resultsWe identified 61 patients with melanoma BM who received WBRT. For the group treated at diagnosis (n = 39): median overall survival was 3 months; best radiographic response included one partial response, ten stable disease, 18 progressive disease, and ten no follow-up imaging. For the group treated at recurrence (n = 22): median overall survival was 3 months; best radiographic response was three partial response, four stable disease, eight progressive disease, and seven no follow-up imaging.

conclusionWBRT activity was limited; however, its role in symptom palliation is unclear.

Indexed as

AdultAgedAged, 80 and overBrain NeoplasmsCranial IrradiationFemaleHumansKaplan-Meier EstimateMaleMelanomaMiddle AgedRetrospective StudiesTreatment OutcomeYoung Adultbrain metastasesipilimumabmelanomaoverall survivalradiographic responseWBRT

Identifiers

PMID25438811
PMCPMC6113948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.